summary
Introduced
12/22/2023
12/22/2023
In Committee
12/22/2023
12/22/2023
Crossed Over
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
A BILL To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
AI Summary
This bill, the Defense Production and Active Pharmaceutical Ingredients Act, proposes to amend the National Defense Authorization Act for Fiscal Year 2023 to extend federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients, such as active pharmaceutical ingredients and key starting materials.
Committee Categories
Military Affairs and Security
Sponsors (1)
Last Action
Referred to the House Committee on Armed Services. (on 12/22/2023)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/6895/all-info |
| BillText | https://www.congress.gov/118/bills/hr6895/BILLS-118hr6895ih.pdf |
Loading...